Según duración y tipo de agente | 29 SEP 19

Profilaxis quirúrgica y eventos adversos por antibióticos

Este estudio de cohorte nacional evalúa la asociación del tipo y la duración de la profilaxis con la infección del sitio quirúrgico, la lesión renal aguda y la infección por Clostridium difficile.
Autor/a: Branch-Elliman W, O’Brien W, Strymish J, Itani K, Wyatt C, Gupta K JAMA Surg 2019; 154(7): 590-598
INDICE:  1. Texto principal | 2. Referencias bibliográficas
Referencias bibliográficas
  1. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al; Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017.JAMA Surg. 2017;152 (8):784-791.
  2. Bratzler DW, Dellinger EP, Olsen KM, et al; American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195-283.
  3. Ban KA, Minei JP, Laronga C, et al. Executive summary of the American College of Surgeons/Surgical Infection Society surgical site infection guidelines: 2016 update. Surg Infect (Larchmt). 2017;18(4):379-382.
  4. McDonald M, Grabsch E, Marshall C, Forbes A. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg. 1998;68(6):388-396.
  5. Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011.JAMA. 2016;315(17):1864-1873.
  6. Bamgbola O. Review of vancomycin-induced renal toxicity: an update. TherAdvEndocrinolMetab. 2016;7(3):136-147.
  7. Hanrahan TP, Kotapati C, Roberts MJ, et al. Factors associated with vancomycin nephrotoxicity in the critically ill. Anaesth Intensive Care. 2015;43 (5):594-599.
  8. Burgess LD, Drew RH. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Pharmacotherapy. 2014;34(7):670-676.
  9. Crabtree T, Aitchison D, Meyers BF, et al. Clostridium difficile in cardiac surgery: risk factors and impact on postoperative outcome. Ann Thorac Surg. 2007;83(4):1396-1402.
  10. Poeran J, Mazumdar M, Rasul R, et al. Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.JThoracCardiovasc Surg. 2016;151(2):589-597.e2.
  11. Balch A, Wendelboe AM, Vesely SK, Bratzler DW. Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile. PLoS One. 2017;12(6):e0179117.
  12. Branch-Elliman W, Ripollone JE, O’Brien WJ, et al. Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus
 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024